The Efficacy and Safety of Lixisenatide in Asian Patients with Type 2 Diabetes (T2D) Insufficiently Controlled with Basal Insulin plus /- Metformin: The GetGoal-L-C Trial

被引：0
|
作者：
Yang, Wenying
Zhang, Nianxian
Niemoeller, Elisabeth
Shang, Shuhua
机构：
来源：
DIABETES | 2016年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1016-P
引用
收藏
页码：A264 / A264
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of lixisenatide in a predominantly Asian population with type 2 diabetes insufficiently controlled with basal insulin: The GetGoal-L-C randomized trial
    Yang, Wenying
    Min, Kyungwan
    Zhou, Zhiguang
    Li, Ling
    Xu, XiangJin
    Zhu, Dalong
    Rao, A. Venkateshwar
    Murthy, Laxminarayanappa Sreenivasa
    Zhang, Nianxian
    Li, Ivy
    Niemoeller, Elisabeth
    Shang, Shuhua
    DIABETES OBESITY & METABOLISM, 2018, 20 (02): : 335 - 343
  • [2] Efficacy and Safety of Once-Daily Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Basal Insulin ± Metformin: GetGoal-L Study
    Riddle, Matthew
    Home, Philip
    Marre, Michel
    Niemoeller, Elisabeth
    Ping, Lin
    Rosenstock, Julio
    DIABETES, 2012, 61 : A251 - A251
  • [3] Efficacy and safety of once-daily lixisenatide in type 2 diabetes insufficiently controlled with basal insulin ± metformin: GetGoal-L study
    Aronson, R.
    Riddle, M.
    Home, P.
    Marre, M.
    Niemoeller, E.
    Ping, L.
    Rosenstock, J.
    DIABETOLOGIA, 2012, 55 : S8 - S8
  • [4] Efficacy and Safety of Lixisenatide in Japanese Patients with Type 2 Diabetes Insufficiently Controlled with Basal Insulin±Sulfonylurea: A Subanalysis of the GetGoal-L-Asia Study
    Seino, Y.
    Ikeda, Y.
    Niemoeller, E.
    Watanabe, D.
    Takagi, H.
    Yabe, D.
    Inagaki, N.
    HORMONE AND METABOLIC RESEARCH, 2015, 47 (12) : 895 - 900
  • [5] Efficacy and safety of lixisenatide once-daily versus placebo in patients with type 2 diabetes mellitus insufficiently controlled on metformin (GetGoal-F1)
    Bolli, G.
    Munteanu, M.
    Dotsenko, S.
    Niemoeller, E.
    Boka, G.
    Hanefeld, M.
    DIABETOLOGIA, 2011, 54 : S316 - S317
  • [6] Efficacy and safety of lixisenatide once-daily versus placebo in patients with type 2 diabetes mellitus insufficiently controlled on sulfonylurea ± metformin (GetGoal-S)
    Ratner, R. E.
    Hanefeld, M.
    Shamanna, P.
    Min, K.
    Boka, G.
    Miossec, P.
    Muehlen-Bartmer, I.
    Rosenstock, J.
    DIABETOLOGIA, 2011, 54 : S317 - S317
  • [7] Efficacy and safety of lixisenatide once-daily versus exenatide twice-daily in patients with type 2 diabetes insufficiently controlled on metformin (GetGoal-X)
    Rosenstock, J.
    Raccah, D.
    Koranyi, L.
    Maffei, L.
    Boka, G.
    Miossec, P.
    Gerich, J. E.
    DIABETOLOGIA, 2011, 54 : S317 - S318
  • [8] Efficacy and safety of lixisenatide once daily vs. placebo in people with Type 2 diabetes insufficiently controlled on metformin (GetGoal-F1)
    Bolli, G. B.
    Munteanu, M.
    Dotsenko, S.
    Niemoeller, E.
    Boka, G.
    Wu, Y.
    Hanefeld, M.
    DIABETIC MEDICINE, 2014, 31 (02) : 176 - 184
  • [9] Efficacy and Safety of Lixisenatide Once Daily Versus Placebo in Patients With Type 2 Diabetes Insufficiently Controlled on Pioglitazone (GetGoal-P)
    Pinget, Michel
    Goldenberg, Ronald
    Niemoeller, Elisabeth
    Muehlen-Bartmer, Isabel
    Aronson, Ronnie
    DIABETES, 2012, 61 : A258 - A258
  • [10] Efficacy and safety of lixisenatide once daily versus placebo in patients with type 2 diabetes insufficiently controlled on pioglitazone (GetGoal-P)
    Pinget, M.
    Goldenberg, R.
    Niemoeller, E.
    Muehlenbartmer, I.
    Aronson, R.
    DIABETOLOGIA, 2012, 55 : S334 - S334
12345